Maravai LifeSciences (MRVI) Analyst & Key Data

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

7

Hold

6

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$6.53

Median Target-5.51%

$6.17

Potential downside vs current price

DCF Value-63.05%

$2.41

Potential downside vs current price

Current Stock Price

$6.53

Median Target-5.51%

$6.17

Potential downside vs current price

DCF Value-63.05%

$2.41

Potential downside vs current price

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

7

Hold

6

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$6.53

Median Target-5.51%

$6.17

Potential downside vs current price

DCF Value-63.05%

$2.41

Potential downside vs current price

Current Stock Price

$6.53

Median Target-5.51%

$6.17

Potential downside vs current price

DCF Value-63.05%

$2.41

Potential downside vs current price

Maravai LifeSciences Holdings, Inc.